Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,11660,258,5.27 [3.99-6.95],9.391488650108374e-32
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,13821,296,2.43 [1.83-3.23],6.806181649534724e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,11660,258,2.42 [1.89-3.09],1.5595090908192645e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,13666,284,2.24 [1.77-2.83],1.2041682122832414e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11660,258,9.12 [6.43-12.93],2.9156878096734625e-35
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,11660,258,2.25 [1.76-2.89],1.393192576720484e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,11911,261,3.44 [2.42-4.88],5.126807823186505e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,13917,294,2.77 [2.04-3.75],5.424073137197821e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,13713,294,3.28 [2.39-4.48],1.2686612053322858e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,13448,290,3.16 [2.26-4.42],1.5083455717821715e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,13923,295,3.99 [2.62-6.07],1.25144282233404e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,13885,295,2.86 [2.17-3.77],6.87497164659738e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,13793,295,4.46 [2.96-6.72],9.403193400845702e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,13760,292,2.01 [1.61-2.51],5.436918929501886e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,13917,294,6.45 [4.82-8.65],9.518379680065192e-36
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13890,294,2.35 [1.87-2.94],9.844038275704133e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,13807,293,1.73 [1.47-2.03],3.7337911878583477e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,11897,262,2.93 [2.11-4.08],1.458748428429448e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,13923,295,2.87 [2.10-3.93],3.3516910501329397e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,11503,254,2.37 [1.92-2.92],6.327856090808067e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,11932,261,3.28 [2.38-4.53],4.761089613669232e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,13923,295,0.46 [0.36-0.58],1.21484691584866e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,13917,294,3.37 [2.35-4.84],4.700483483979195e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,13760,292,3.04 [2.23-4.12],1.15054410362255e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,13890,294,0.64 [0.55-0.74],6.800226890286214e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,13784,296,3.66 [2.47-5.43],1.0811370397466088e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,13890,294,4.60 [2.98-7.10],6.033478181144713e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,13762,293,1.91 [1.56-2.33],2.36051105934977e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,11944,264,9.38 [5.90-14.91],3.163818951235683e-21
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,13637,284,0.62 [0.53-0.72],9.822923855658363e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,13784,296,2.82 [2.11-3.76],1.849770014044338e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,13894,294,2.29 [1.85-2.85],6.183912070654227e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,13737,292,0.33 [0.25-0.45],2.874309783197085e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,13639,284,1.50 [1.35-1.68],1.9875130692542999e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13784,296,0.28 [0.19-0.39],1.6230019782704673e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13893,295,3.69 [2.69-5.07],5.482796080434183e-16
